<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363089">
  <stage>Registered</stage>
  <submitdate>27/09/2012</submitdate>
  <approvaldate>27/09/2012</approvaldate>
  <actrnumber>ACTRN12612001037897</actrnumber>
  <trial_identification>
    <studytitle>The effect that moderate exercise has on the cardiovascular function in sedentary, overweight adults</studytitle>
    <scientifictitle>The effect of perceptually-regulated exercise training on cerebrovascular reactivity function and flow-mediated dilatation in sedentary, overweight adults</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>NIL</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Overweight/obese</healthcondition>
    <healthcondition>sedentary</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>8 week exercise program of 3 times a week, 30 mins per session at a moderate intensity (RPE 13).
The participant will be walking/jogging on a treadmill at a maximum of "somewhat hard". They will be supervised by gym staff who are either qualified exercise physiologists or Human Movement students/graduates.</interventions>
    <comparator>no exercise for the same period. Maintaining the current exercise and dietary behaviours.</comparator>
    <control>Active</control>
    <interventioncode>Lifestyle</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Flow mediated dilatation of the brachial artery - B Mode ultrasound, GE Logiq 7</outcome>
      <timepoint>baseline (week 0) and post intervention (week 8)</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Cerebrovascular reactivity of the middle cerebral artery - Multigon Transcranial Doppler sonography</outcome>
      <timepoint>baseline (week 0) and post intervention (week 8)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>VO2 max using the modified Balke-Ware graded exercise test with online gas analysis</outcome>
      <timepoint>baseline (week 0) and post intervention (week 8)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>30-55 years old
sedentary (exercise less than 30 mins 3 x p/w at a moderate intensity)
BMI 25-40</inclusivecriteria>
    <inclusiveminage>30</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>55</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>cardiovascular or respiratory disease
diabetes
pregnant or lactating
smoking or within 1 year of quitting
any other factors preventing exercise 
medications affecting cardiovascular function</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>the subject is screened using the ESSA adult pre-exercise questionnaire. If fitting within criteria and gives consent then they will be randomly allocated (via stratification) to either the intervention or control group.
allocation will be done by a person not involved in screening or testing.</concealment>
    <sequence>stratified randomisation based on age, gender and BMI. Randomisation will be done in microsoft excel by a non-involved person in testing and data analysis.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>2/10/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of South Australia</primarysponsorname>
    <primarysponsoraddress>251-261 North Terrace, Adelaide, South Australia, 5000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of South Australia</fundingname>
      <fundingaddress>251-261 North Terrace, Adelaide, South Australia, 5000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We are looking at the effects of exercise compared to no exercise on the cardiovascular function in the peripheral (arm) and cerebral (head) arteries.
We expect to see a change in the peripheral and cerebral arteries from exercise.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee</ethicname>
      <ethicaddress>251-261 North Terrace, Adelaide, South Australia, 5000</ethicaddress>
      <ethicapprovaldate>12/09/2012</ethicapprovaldate>
      <hrec>0000030272</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Kendall Morrison</name>
      <address>251-261 North Terrace, Adelaide, South Australia, 5000</address>
      <phone>+61 8 8302 2287</phone>
      <fax />
      <email>morkl009@mymail.unisa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Kendall Morrison</name>
      <address>251-261 North Terrace, Adelaide, South Australia, 5000</address>
      <phone>+61 8 8302 2287</phone>
      <fax />
      <email>morkl009@mymail.unisa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>